Davis Polk & Wardwell LLP

Resourced out of Hong Kong by lawyers with local and New York qualifications (and also able to leverage a sizeable presence in Beijing), Davis Polk & Wardwell LLP has a strong reputation advising Chinese companies on their Hong Kong IPOs and affiliated Reg S/Rule 144A international offerings, as well as on their US listings. In spite of a continued antagonistic relationship between US and China and an uncertain regulatory environment, notably Li He advised ZEEKR Intelligent Technology Holding on its $441m IPO on the NYSE – in what was the largest IPO by a Chinese company in the US since July 2021. Many of the life sciences IPOs (including all the 18A listings handled by the firm) are led by Steve Wang, who provides added industry insight by dint of his academic qualifications which includes a Phd in cell biology. James Lin co-heads the team alongside He and Wang.